Lexeo Therapeutics (NASDAQ:LXEO) Earns Buy Rating from Analysts at Chardan Capital
Chardan Capital assumed coverage on shares of Lexeo Therapeutics (NASDAQ:LXEO – Free Report) in a report released on Tuesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $23.00 target price on the stock. Lexeo Therapeutics Price Performance Shares of LXEO opened at $12.72 on Tuesday. Lexeo Therapeutics has a 52 week low […]
More Stories
Aeries Technology (AERT) & Its Competitors Head-To-Head Comparison
Profitability This table compares Aeries Technology and its peers’ net margins, return on equity and return on assets. Net Margins...
Insider Selling: Secure Energy Services Inc. (TSE:SES) Insider Sells 2,995 Shares of Stock
Secure Energy Services Inc. (TSE:SES – Get Free Report) insider David Bonderman sold 2,995 shares of the company’s stock in...
Tensions Rise Over ICC Arrest Warrants for Netanyahu, Gallant as US Allies Mull Response
By Tom Ozimek Controversy is intensifying and the stakes are rising over the International Criminal Court’s (ICC) recent decision to...
WisdomTree U.S. High Yield Corporate Bond Fund Declares Dividend of $0.24 (NYSEARCA:QHY)
WisdomTree U.S. High Yield Corporate Bond Fund (NYSEARCA:QHY – Get Free Report) announced a dividend on Friday, November 22nd,NASDAQ Dividends...
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD) Announces Dividend of $0.14
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD – Get Free Report) announced a dividend on Friday, November 22nd,NASDAQ Dividends reports....
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY) Plans Dividend Increase – $0.16 Per Share
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY – Get Free Report) announced a dividend on Saturday, November 23rd,NASDAQ Dividends reports....